IMMUNO-COV™ – The Test for Antibodies that Block SARS-CoV-2 Infection Read More

In the News

November 12, 2021

Leveraging Virus Power To Beat Cancer With Vyriad

DNA Weekly

Vyriad is developing the next generation of targeted cancer therapies using engineered viruses that selectively attack cancer cells and ignite robust immune responses to prevent cancer recurrence. I sat down for a fascinating conversation with Stephen Russell, Co-founder and CEO of Vyriad, to hear about this incredible technology and its potential to transform oncology treatment forever.

October 21, 2021

Children with mild COVID-19 may not develop antibodies; oral vaccine booster shows promise in monkey study


A COVID-19 booster vaccine that can be given by mouth to people who already have antibodies from vaccination or prior infection has yielded promising results in monkeys and is likely to be tested soon in humans, according to the company developing it. A report of the study posted on Monday on bioRxiv ahead of peer review says Vyriad is working with the U.S. Food and Drug Administration to plan human trials.

August 23, 2021

Med City firm’s test helps answer the question of how immune you are


Immunocompromised Washington, D.C., attorney Samuel Shafner was unsure of his risks, even though he was vaccinated. A desire for more detailed answers about his immunity led him to Rochester’s Imanis Life Sciences and its Immuno-Cov test.

May 24, 2021

Using Viruses to Treat Cancer

Oncology Convention

Speaking on the latest episode of the Biotech 2050 podcast, Alice Bexon, the Chief Medical Officer for Vyriad, discussed the history of oncologic viruses and recent developments which she had been involved in

March 10, 2021

What to do it you test positive for COVID-19 today


Got a positive COVID-19 test? Take a deep breath and use this guide to make sense of the situation.

March 10, 2021

Can Non-Vaccinated People Get Vaccinated People Sick With COVID-19?

Verywell Health

Key Takeaways: Non-vaccinated people can still get vaccinated people sick with COVID-19. Vaccinated people who contract COVID-19 may have less severe symptoms because the body mounts an immune response and adapts to prevent the coronavirus from replicating. More research is needed about how the COVID-19 vaccines respond to emerging variants.

February 25, 2021

Rochester’s Vyriad developing oral COVID-19 vaccine


Vyriad, a Rochester biotech firm founded by Mayo Clinic researchers, is developing an oral vaccine for the coronavirus that could be used as a booster in the months after the initial wave of vaccinations.

February 16, 2021

Company in Rochester, Minnesota Developing Oral COVID-19 Vaccine


Vyriad, a scientific research lab based in Rochester, Minnesota, started working on a COVID-19 vaccine early last year and lab testing shows its delivery method and properties could give people immunity to the virus.

January 13, 2021

The 20 Hottest Digital Health Startups From Flyover Country, 2021


The Observer, in advance of the JP Morgan Healthcare Conference, names Imanis Life Sciences and sister company Vyriad as one of the hottest health startups from flyover country of 2021.

December 23, 2020

Heroes of the COVID Crisis: How Stephen Russel & Imanis Life Sciences Stepped Up to Make a Difference During the Pandemic

Authority Magazine

Imanis Life Sciences CEO and co-founder, Dr. Stephen Russell, talks to Authority Magazine about Heroes – what makes a hero, heroes in his own life, and heroes amid the current world climate.

December 17, 2020

If You’ve Already Had COVID-19, Do You Need the Vaccine? Here’s What Experts Say


As the long-awaited COVID-19 vaccine distribution process begins in the United States, there’s plenty of deliberation around who gets the vaccine, and when.

December 9, 2020

New COVID-19 antibody test developed in Rochester


While many wait for news of a COVID-19 vaccine in the United States, a Rochester company says it has created something that can help figure out if you can fight the virus off on your own.

December 9, 2020

Antibody test puts Rochester at forefront of tracking COVID-19 immunity


How immune are you? That’s the question developers of a new COVID-19 antibody test or assay hope to answer for patients and doctors.

December 7, 2020

New test by Minnesota biotech firm can read COVID antibody levels

Star Tribune

So, what’s your titer? That question, still strange sounding, may soon become important as vaccines bring about the endgame for COVID-19.

November 19, 2020

Dueling quantitative COVID-19 neutralizing antibody tests roll out as vaccines approach completion


As COVID-19 vaccines ready themselves for market, two companies have turned their attention to what comes next – verifying whether the vaccines provide effective and lasting protection against SARS-CoV-2.

November 9, 2020

Study suggests herd immunity to COVID-19 in New York City is low

Medical News

Researchers in the United States have estimated that the proportion of people in New York City who developed antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the first wave of the coronavirus disease 2019 (COVID-19) pandemic is around one in eight.

October 4, 2020

Transforming the Treatment of Cancer with Oncolytic Viruses

Decision Resources Group "Conversations in Health"

August 28, 2020

Heroes of the Pandemic

Star Tribune

Six months now into this perplexing and powerful pandemic, we’ve grown accustomed to seeing our “front line” heroes whenever we venture out and also when we don’t.

July 20, 2020

Anti-cancer start-up doses first patient in new clinical trial


Vyriad, a growing Rochester biotech firm founded by Mayo Clinic researcher Dr. Kah-Whye Peng and Dr. Stephen Russell, has started dosing of the first patient in a Phase 2 clinical trial of a possible late-stage cancer treatment.

June 12, 2020

Mayo Clinic Unveils New Antibody Test for COVID-19

KARE 11 News

June 11, 2020

Mayo Clinic Unveils Key COVID-19 Antibody Test

Star Tribune

June 11, 2020

Vyriad CEO Stephen Russell discusses neutralizing antibody testing

Myeloma Crowd Radio

May 22, 2020

University of Minnesota’s Infectious Disease Center Urges Better Use of COVID-19 Testing

Star Tribune

May 13, 2020

Rochester Scientists Develop First-of-its-Kind Antibody Test to Detect Protective Immunity

Med City Beat

March 4, 2020

Dr. Stephen Russell Participates in “Creating a Cluster of Innovation in Rochester” Podcast

Finance & Commerce

November 21, 2019

Rochester Cancer-Therapy Firm to Collaborate with Drugmaker on Melanoma Treatment

Star Tribune

November 6, 2019

Rochester Biotech Firm Strikes ‘Significant’ Deal with Drug Maker

Rochester Post-Bulletin

September 3, 2019

From Concept to Company: An Anti-Cancer Idea Goes Viral

Discovery's Edge

March 8, 2019

Vyriad: Hoping to Cure Cancer with a Single Shot


January 31, 2019

Vyriad Moves to Former IBM Complex


January 17, 2019

State of the Art Cancer Therapeutics Manufacturing Headquarters Celebrates Grand Opening in Rochester Next Week

Rochester Rising

July 27, 2018

Vyriad Expands Phase 1 Trial to Test Voyager-V1 in Combination with Bevencio for Colorectal Cancer

Immuno-Oncology News

June 11, 2018

Mayo Clinic patient treated by massive measles dose still cancer-free 5 years later

Star Tribune

March 28, 2018

Mayo Clinic Biotech Spin-Off Vyriad Raising $9M for Expansion, Clinical Trials

Twin Cities Business

August 13, 2017

Oncolytic Virotherapy: A New Cornerstone for Immuno-Oncology

Journal of Oncology

August 8, 2014

Giving Viruses a License to Kill… Cancer

Science Friday